Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2003
09/03/2003CN1439403A Preparing method for Chinese herbal medicine against calculus in digestive canal
09/03/2003CN1439393A Preparing method for removing impurities in Chinese herbal preparations
09/03/2003CN1439392A Chinese medicinal herb healthy wine
09/03/2003CN1439384A Medicine for gastrosia
09/03/2003CN1439371A Matrine sustained releasing agent and its preparing process
09/03/2003CN1439363A Dichloroacetic acid diisopropylamine oral preparation and its preparation process-treatment of liver function injury
09/03/2003CN1439309A Composite solid sprulina healthy beverage and its preparation
09/03/2003CN1120157C Substituted quinoline-2-carboxylic acid amidesuand their preparation and their use as medicaments and intermediate products
09/03/2003CN1120018C Instant particles ÔÇÿYigansanÔÇÖ"
09/03/2003CN1120013C Medicine for baldness caused by liver and kidney dificiency and its preparation
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613905 Chemokine receptor antagonists and methods of use therefor
09/02/2003US6613778 Imidazopyridine derivatives as phosphodiesterase VII inhibitors
09/02/2003US6613775 Imidazo[1,2-a]pyridine compounds
09/02/2003US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
09/02/2003US6613770 Quinoline derivatives as NK-2 and NK-3 receptor ligands
09/02/2003US6613769 Tryptase inhibitors
09/02/2003US6613760 Indole derivatives and their use as MCP-1 receptor antagonists
09/02/2003US6613739 Immunosuppressants
09/02/2003US6613549 Prevention, therapy intestinal infections
09/02/2003US6613345 Conjugates of sodium channel blockers and methods of using the same
09/02/2003US6613322 Administering enzyme inhibitors
09/02/2003CA2081709C Controlled release pharmaceutical compositions
08/2003
08/28/2003WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA)
08/28/2003WO2003070969A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070919A1 Antimicrobial composition
08/28/2003WO2003070918A2 Rna interference by modified short interfering nucleic acid
08/28/2003WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r)
08/28/2003WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid
08/28/2003WO2003070764A1 Method for producing interferon
08/28/2003WO2003070750A2 Rna interference mediated inhibition of hepatitis c virus
08/28/2003WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070738A2 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003WO2003070711A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
08/28/2003WO2003070709A1 Novel phenylalanine derivative
08/28/2003WO2003070706A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003WO2003070245A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003WO2003070235A1 Medicinal compositions for inhibiting tryptase
08/28/2003WO2003070232A1 Anti-nausea and anti-vomiting activity of cannabidiol compounds
08/28/2003WO2003070218A1 Sustained-release ointment for topical administration
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070184A2 Sodium channel blockers
08/28/2003WO2003070182A2 Sodium channel blockers
08/28/2003WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003WO2003070153A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003WO2003070023A1 Amino acid powder and process for producing the same
08/28/2003WO2003069972A2 Hepatocyte precursor cell lines
08/28/2003WO2003031447A3 Pyrimidine derivatives
08/28/2003WO2003025015A3 A soluble toll-like receptor
08/28/2003WO2003015656A3 Oral care substance delivery strip
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003004007A3 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd)
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002081508A3 Use of cd25 binding molecules in steroid-resistant patients
08/28/2003WO2002062369A3 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002043771A3 Conjugates of glycosylated/galactosylated peptide
08/28/2003WO2002041880A3 Use of pyrazolo[4,3-d]pyrimidines
08/28/2003WO2002040005A3 Blockade of sodium channels by phenol derivatives
08/28/2003WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2001095859A3 Novel heterocyclic analogs of diphenylethylene compounds
08/28/2003WO2001082949A3 Method of reducing side effects of chemotherapy in cancer patients
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162836 Microbiocides
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/28/2003US20030162807 Compositions and methods for treating osteoporosis and lowering cholesterol
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162801 Tricyclic compounds and their uses
08/28/2003US20030162798 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
08/28/2003US20030162794 Benzazole derivatives and their use as jnk modulators
08/28/2003US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162772 For example, N-(2-(3-((1-(3,4-dichlorobenzylpiperidinyl) aminohydroxypropoxy)phenyl)acetamide; use as modulators of chemokine receptor activity, and may be used in treatment of autoimmune, inflammatory, proliferative diseases
08/28/2003US20030162771 Have an antagonistic activity with respect to corticotropin releasing factor
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
08/28/2003US20030162765 Use in treatment and prevention of central nervous system and other disorders
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162741 Oral DNA composition for hepatitis B virus chronic infection
08/28/2003US20030162300 Galactomannan-oligosaccharides and methods for the production and use thereof
08/28/2003US20030162252 Isolating cDNAs encoding novel G protein-coupled receptor proteins derived from human spleen
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161884 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/28/2003US20030161877 Administering mixtures of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol -3-thione (oltipraz) and dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2, 2'-dicarboxylate (DDB) for prophylaxis of liver disorders; nontoxic
08/28/2003US20030161863 Administering mixtures of nutrients for prophylaxis of muscular, metabolic or respiratory disorders, injuries, inflammation and/or to relieve stress
08/28/2003US20030161826 Therapy for autoimmune disease; central nervous system disorders
1 ... 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 ... 1258